Background: Obstructive sleep apnoea (OSA) is highly prevalent and significantly
associated with major adverse cardiovascular events (MACEs). Continuous positive airway …

Aims To assess whether continuous positive airway pressure (CPAP) therapy reduces major
adverse cardiovascular events (MACE) in patients with moderate-to-severe obstructive …

Obstructive sleep apnea (OSA) commonly occurs in patients with increased cardiovascular
(CV) risk, and continuous positive airway pressure (CPAP) is the preferred therapy for these …

While continuous positive airway pressure (CPAP) therapy has a strong evidence base for
the treatment of obstructive sleep apnoea (OSA), its impact on cardiovascular comorbidity …

The prevalence of obstructive sleep apnea (OSA) is 3% to 7% in the general population [1].
OSA has been found to be associated with cardiovascular disease, leading to high rates of …

© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2016; 8 (12): E1644-E1646
jtd. amegroups. com group] and there was also a significant improvement in health-related …

Study Objectives: This meta-analysis aimed to systematically assess the effects of
continuous positive airway pressure (CPAP) in secondary prevention of major …

Purpose Continuous positive airway pressure (CPAP) therapy may decrease the risk of
mortality and cardiovascular events in patients with obstructive sleep apnea. However, these …

Background It remains uncertain whether continuous positive airway pressure (CPAP)
therapy would significantly impact hard clinical outcomes in patients with obstructive sleep …

Prospective studies show an association between obstructive sleep apnea and
cardiovascular disease. Continuous positive airway pressure (CPAP) is the treatment of …